Cargando…

Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype

BACKGROUND: Parathyroid carcinoma (PC) is a rare malignancy, the incidence of which is less than 1/1 million per year. Sarcomatoid parathyroid carcinoma (SaPC) is an extremely peculiar subtype; only three cases have been reported internationally. It consists of both malignant epithelial components a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yongchao, Wang, Yue, Wu, Qingcheng, Zhao, Xuzi, Liu, Deshun, Zhao, Yongfu, Li, Yuguo, Wang, Guangzhi, Xu, Jingchao, Chen, Junzhu, Zhang, Ning, Tian, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719313/
https://www.ncbi.nlm.nih.gov/pubmed/34975762
http://dx.doi.org/10.3389/fendo.2021.793718
_version_ 1784624911281553408
author Yu, Yongchao
Wang, Yue
Wu, Qingcheng
Zhao, Xuzi
Liu, Deshun
Zhao, Yongfu
Li, Yuguo
Wang, Guangzhi
Xu, Jingchao
Chen, Junzhu
Zhang, Ning
Tian, Xiaofeng
author_facet Yu, Yongchao
Wang, Yue
Wu, Qingcheng
Zhao, Xuzi
Liu, Deshun
Zhao, Yongfu
Li, Yuguo
Wang, Guangzhi
Xu, Jingchao
Chen, Junzhu
Zhang, Ning
Tian, Xiaofeng
author_sort Yu, Yongchao
collection PubMed
description BACKGROUND: Parathyroid carcinoma (PC) is a rare malignancy, the incidence of which is less than 1/1 million per year. Sarcomatoid parathyroid carcinoma (SaPC) is an extremely peculiar subtype; only three cases have been reported internationally. It consists of both malignant epithelial components and sarcomatoid components (mesenchymal origin) simultaneously. This “confusing” cancer exhibits higher invasiveness, and traditional surgery does not appear to achieve the expectation, which differs significantly from that of general PC. OBJECTIVE: To characterize the clinicopathologic features of SaPC and explore similarities and differences between SaPC and general PC. MATERIALS AND METHODS: We collected clinical data of SaPC cases from our center and literature. The SaPC case in our center was presented. To better understand the characteristics of SaPC, we also reviewed clinical information in general PC cases from our center and literature within the last 5 years, and a systematic review was performed for further comparison. RESULTS: A 60-year-old woman was admitted for a neck mass and hoarseness. After the surgery, she was confirmed as SaPC and ultimately developed local recurrence at 3 months. Together with the reported cases from literature, four cases of SaPC (three cases from literature) and 203 cases of general PC (200 cases from literature) were reviewed. Both tumors showed obvious abnormalities in parathormone (PTH) level and gland size. Compared to general PC, SaPC has a later age of onset (60.50 ± 7.42 vs. 51.50 ± 8.29), relatively low levels of PTH (110.28 ± 59.32 vs. 1,156.07 ± 858.18), and a larger tumor size (6.00 ± 1.63 vs. 3.14 ± 0.70). For SaPC, all four cases were initially misdiagnosed as thyroid tumors (4/4). Spindle cell areas or transitional zones were common pathological features in SaPC cases (3/4). CONCLUSION: SaPC is a very rare pathologic subtype of PC and appears to be much more easily misdiagnosed as a thyroid tumor. Spindle cell areas or transitional zones are highly possible to be pathological features in its sarcomatoid components. Despite many similarities, there are some differences between SaPC and general PC—SaPC does not show the obvious endocrine feature but stronger aggressiveness. Surgical treatment of SaPC does relieve life-threatening symptoms and improve quality of life even with recurrence in the short term.
format Online
Article
Text
id pubmed-8719313
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87193132022-01-01 Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype Yu, Yongchao Wang, Yue Wu, Qingcheng Zhao, Xuzi Liu, Deshun Zhao, Yongfu Li, Yuguo Wang, Guangzhi Xu, Jingchao Chen, Junzhu Zhang, Ning Tian, Xiaofeng Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Parathyroid carcinoma (PC) is a rare malignancy, the incidence of which is less than 1/1 million per year. Sarcomatoid parathyroid carcinoma (SaPC) is an extremely peculiar subtype; only three cases have been reported internationally. It consists of both malignant epithelial components and sarcomatoid components (mesenchymal origin) simultaneously. This “confusing” cancer exhibits higher invasiveness, and traditional surgery does not appear to achieve the expectation, which differs significantly from that of general PC. OBJECTIVE: To characterize the clinicopathologic features of SaPC and explore similarities and differences between SaPC and general PC. MATERIALS AND METHODS: We collected clinical data of SaPC cases from our center and literature. The SaPC case in our center was presented. To better understand the characteristics of SaPC, we also reviewed clinical information in general PC cases from our center and literature within the last 5 years, and a systematic review was performed for further comparison. RESULTS: A 60-year-old woman was admitted for a neck mass and hoarseness. After the surgery, she was confirmed as SaPC and ultimately developed local recurrence at 3 months. Together with the reported cases from literature, four cases of SaPC (three cases from literature) and 203 cases of general PC (200 cases from literature) were reviewed. Both tumors showed obvious abnormalities in parathormone (PTH) level and gland size. Compared to general PC, SaPC has a later age of onset (60.50 ± 7.42 vs. 51.50 ± 8.29), relatively low levels of PTH (110.28 ± 59.32 vs. 1,156.07 ± 858.18), and a larger tumor size (6.00 ± 1.63 vs. 3.14 ± 0.70). For SaPC, all four cases were initially misdiagnosed as thyroid tumors (4/4). Spindle cell areas or transitional zones were common pathological features in SaPC cases (3/4). CONCLUSION: SaPC is a very rare pathologic subtype of PC and appears to be much more easily misdiagnosed as a thyroid tumor. Spindle cell areas or transitional zones are highly possible to be pathological features in its sarcomatoid components. Despite many similarities, there are some differences between SaPC and general PC—SaPC does not show the obvious endocrine feature but stronger aggressiveness. Surgical treatment of SaPC does relieve life-threatening symptoms and improve quality of life even with recurrence in the short term. Frontiers Media S.A. 2021-12-15 /pmc/articles/PMC8719313/ /pubmed/34975762 http://dx.doi.org/10.3389/fendo.2021.793718 Text en Copyright © 2021 Yu, Wang, Wu, Zhao, Liu, Zhao, Li, Wang, Xu, Chen, Zhang and Tian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yu, Yongchao
Wang, Yue
Wu, Qingcheng
Zhao, Xuzi
Liu, Deshun
Zhao, Yongfu
Li, Yuguo
Wang, Guangzhi
Xu, Jingchao
Chen, Junzhu
Zhang, Ning
Tian, Xiaofeng
Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype
title Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype
title_full Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype
title_fullStr Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype
title_full_unstemmed Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype
title_short Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype
title_sort case report and systematic review: sarcomatoid parathyroid carcinoma—a rare, highly malignant subtype
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719313/
https://www.ncbi.nlm.nih.gov/pubmed/34975762
http://dx.doi.org/10.3389/fendo.2021.793718
work_keys_str_mv AT yuyongchao casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT wangyue casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT wuqingcheng casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT zhaoxuzi casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT liudeshun casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT zhaoyongfu casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT liyuguo casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT wangguangzhi casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT xujingchao casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT chenjunzhu casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT zhangning casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype
AT tianxiaofeng casereportandsystematicreviewsarcomatoidparathyroidcarcinomaararehighlymalignantsubtype